Pfizer says COVID-19 vaccine protected, beneficial for kids a long time 5 to 11

What we comprehend about the Pfizer COVID-19 booster shot

SHARE

SHARE

TWEET

SHARE

e mail

click on to expand

UP next

data shows the Pfizer and BioNTech COVID-19 vaccine is safe and beneficial for toddlers a long time 5 to eleven, the companies introduced Monday morning.

"we're wanting to extend the coverage afforded through the vaccine to this younger population, field to regulatory authorization, peculiarly as we song the spread of the delta variant and the colossal probability it poses to children," Pfizer chairman and CEO Albert Bourla stated in a press release. "due to the fact that July, pediatric cases of COVID-19 have risen with the aid of about 240 % within the U.S. -- underscoring the public fitness want for vaccination."

© Matt Rourke/AP more: These vaccine mandates are already in place to attend college in the US

there were 2,268 contributors ages 5 to 11 in the trial, which, while it still adopted a two-dose regimen, used a lesser dose than the amount given to people ages 12 and older, for the "security, tolerability and immunogenicity" of younger babies.

"In members 5 to 11 years of age, the vaccine become safe, well-tolerated and confirmed potent neutralizing antibody responses," the companies said in a information unlock.

© Matt Rourke/AP A syringe is ready with the Pfizer COVID-19 vaccine at a hospital on the studying area group faculty in studying, Pa., Sept. 14, 2021.

Pfizer and BioNTech plan to share their information with the U.S. meals and Drug Administration, the european medicines agency and different regulators soon and will put up a request for emergency use authorization in the united states.

The FDA accepted the Pfizer vaccine, which is marketed as Comirnaty, for people a long time 16 and older in August. it is presently licensed for emergency use in children ages 12 to 15.

more: Alaska once had the optimum vaccination cost. Now it's in a COVID-19 crisis.

"These trial results supply a robust basis for in quest of authorization of our vaccine for toddlers 5 to eleven years historic, and we plan to post them to the FDA and different regulators with urgency," Bourla stated.

effects from two different ongoing trials -- certainly one of children ages 2 to five and one in every of children 6 months to 2 years old -- are anticipated as quickly as later this yr, the businesses mentioned.

Pfizer has additionally got emergency use authorization from the FDA to supply a 3rd dose of vaccine to those 12 years of age and older who have been decided to have certain types of immunocompromise.

greater: FDA advisers reject Biden's plan to present Pfizer boosters for all, embraces 3rd pictures for older, at-risk american citizens best

besides the fact that children, a panel advising the federal government on vaccines recently rejected President Joe Biden's advice to roll out booster shots for all americans, recommending that for now, a 3rd dose may still best receive to those sixty five and older or these at excessive chance of extreme COVID-19.